Welcome to our dedicated page for DIH Holdings US SEC filings (Ticker: DHAI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The DIH Holding US, Inc. (DHAI) SEC filings page on Stock Titan brings together the company’s official disclosures as filed with the U.S. Securities and Exchange Commission. DIH operates in the healthcare sector within the medical devices industry and has described itself as a global provider of advanced robotic devices for physical rehabilitation. Its filings provide detailed information on financial performance, capital structure, listing status, and corporate governance.
Through annual reports on Form 10-K and quarterly reports on Form 10-Q, DIH presents audited and interim financial statements, including revenue from devices and services, gross profit, operating expenses, research and development costs, and cash balances. These periodic reports also discuss matters such as product mix, regional sales trends, and impairment charges associated with discontinued product development and software projects.
Current reports on Form 8-K are particularly important for DIH. The company has filed multiple 8-Ks describing notices from Nasdaq about non-compliance with market value, bid price, and reporting rules; the approval and implementation of a 1-for-25 reverse stock split; and the Nasdaq Hearings Panel decision that led to delisting and suspension of trading on Nasdaq. Other 8-Ks detail financing transactions, including senior secured convertible debentures and a common share purchase agreement, as well as board appointments, leadership resignations, and the company’s disclosure that there is substantial doubt about its ability to continue as a going concern.
On this page, users can access DIH’s 8-Ks, 10-Ks, and 10-Qs as they are made available through EDGAR, along with AI-powered summaries that highlight key points such as going concern language, delisting events, capital raises, and changes in executive leadership. Form 4 and related insider transaction reports, when filed, can be reviewed to see how directors and officers transact in DHAI securities. This combination of real-time filings and AI explanations can help readers understand the regulatory and financial history of DIH Holding US, Inc.
DIH Holding US, Inc. is having its Class A common stock and warrants removed from listing and/or registration on the Nasdaq Stock Market LLC. Nasdaq filed a Form 25 under Section 12(b) of the Securities Exchange Act of 1934, certifying it has met the regulatory requirements to strike these securities from the exchange. This action means the company’s common shares and related warrants will no longer trade on Nasdaq, which typically reduces trading liquidity and shifts any future trading to alternative markets, if available.
DIH Holding US, Inc. disclosed that Jason Chen, its former Chief Executive Officer, has also resigned from the company’s Board of Directors. The filing explains that Mr. Chen had previously notified the Board on November 24, 2025 that he was resigning as Chief Executive Officer and on November 25, 2025 that he was resigning from similar positions at all subsidiaries. On December 15, 2025, he further notified the Board that he was resigning as a director of the company, including all committee memberships, with his resignation effective upon notice.
DIH Holding US, Inc. reported a major leadership change. On November 24, 2025, Chief Executive Officer Jason Chen notified the Board that he was resigning as CEO of the company, effective immediately. On November 25, 2025, he also resigned from all similar positions at the company’s subsidiaries.
Although Jason Chen has stepped down from his executive roles, he will remain a member of the Board of Directors, so he will still be involved in overseeing the company at the board level. The Board has not yet appointed a replacement CEO, leaving a temporary gap in day-to-day executive leadership while a successor is identified.
DIH Holding US, Inc. (DHAI) announced its Nasdaq delisting. A Nasdaq Hearings Panel denied the company’s request to remain listed, and trading in its securities will be suspended at the open on November 7, 2025. The company’s Class A common stock and warrants had traded on Nasdaq under DHAI and DHAIW.
The company does not intend to seek further review of the decision. It plans to have its securities quoted over the counter under the same symbols, but warns there may be a very limited market and that shareholders may find it difficult to sell shares, with trading prices potentially adversely affected.
Management and auditors had previously noted substantial doubt about the company’s ability to continue as a going concern. Following the delisting decision, the company concluded additional capital needed for day-to-day operations will be unavailable and has suspended operations while evaluating strategic alternatives.
DIH Holding US, Inc. entered a common shares purchase agreement with an investor, enabling sales of up to the lesser of $22,000,000 in aggregate gross purchase price or 10,458,031 Class A common shares in a private placement. Purchases will be priced at 94% of the lowest daily VWAP over the prior three trading days including the purchase date.
As a commitment fee, the investor received 100,000 shares and a pre-funded warrant for 100,000 shares, which are to be returned if the Company’s Nasdaq Hearings Panel Appeal is not successful. DIH plans to use net proceeds for working capital and general purposes and will file a resale registration statement within 45 trading days. The agreement terminates on the first day of the month following the 36‑month anniversary of the initial registration statement’s effective date.
DIH Holding US, Inc. (DHAI) furnished an 8-K announcing its fourth quarter and fiscal year ended March 31, 2025 financial results. The company issued a press release on October 20, 2025, which is included as Exhibit 99.1.
The filing is informational, pointing investors to the press release for details. DIH Holding’s Class A Common Stock (DHAI) and Warrants (DHAIW) are listed on The Nasdaq Stock Market LLC.
DIH Holding US, Inc. (DHAI) filed its annual report detailing a global rehab robotics business focused on upper and lower extremity recovery devices and interactive motion platforms. The company completed a business combination with Aurora Technology Acquisition Corp. on February 7, 2024, but has not completed its planned reorganization to acquire Motek Group and Hocoma AG; it continues to source Motek products under an exclusive distribution agreement.
Management disclosed substantial doubt about continuing as a going concern. Cash and cash equivalents were $1.9 million as of March 31, 2025, with an accumulated deficit of $43.9 million as of March 31, 2025. Revenue is concentrated in EMEA and the Americas, and around core products—Lokomat (>45%) plus Erigo, Armeo, C‑Mill, and CAREN/GRAIL (~90% combined). On October 17, 2025, the company effected a 1‑for‑25 reverse stock split; 2,092,653 common shares were outstanding as of that date. The market value of non‑affiliate equity was $38,873,419 as of September 30, 2024.
DIH Holding US, Inc. (DHAI) enacted a one-for-twenty-five reverse stock split of its Class A common stock, effective at 5:00 p.m. Eastern Time on
The reverse split does not change the total number of authorized shares. No fractional shares were issued; holders otherwise entitled to a fraction will receive one whole share. Outstanding options and warrants were adjusted proportionately. Continental Stock Transfer & Trust Company is serving as exchange agent.
DIH Holding US, Inc. reports that Nasdaq is now considering multiple listing deficiencies that could lead to delisting of its Class A common stock and warrants. The company failed to regain compliance with Nasdaq’s market value of publicly held shares rule, which requires at least
On October 7, 2025, Nasdaq’s Hearings Panel informed the company it will factor this new deficiency into its decision on continued listing. DIH has requested a hearing and a stay of suspension while it presents a plan to regain compliance with all rules, including overdue Form 10‑Q and Form 10‑K reports. The Panel may grant time extensions, but there is no assurance DIH will maintain its Nasdaq Global Market listing.
DIH Holding US, Inc. reports that Nasdaq has added multiple listing deficiencies as bases for potential delisting of its Class A common stock. The company previously failed to meet the $1.00 bid price requirement by the September 8, 2025 compliance date, and on September 12, 2025 Nasdaq staff notified DIH that this shortfall is an additional basis for delisting. DIH clarifies that the same notice also cited its failure to file its Form 10-Q for the period ended June 30, 2025 and Form 10-K for the year ended March 31, 2025 under the Nasdaq Reports Rule.
The company has requested a hearing before a Nasdaq Hearing Panel, which has stayed suspension of trading for 15 days while DIH seeks an additional stay. At the hearing, the company plans to present a plan to regain compliance with the market value of listed securities rule (MVLS Rule), the bid price rule, and the reports rule, and may receive up to 180 days from the delisting determination for MVLS and bid price issues and up to 360 days from the initial filing delinquency to cure its reporting delays. DIH notes there is no assurance the Panel will grant continued listing or sufficient time to regain compliance.
FAQ
What is the current stock price of DIH Holdings US (DHAI)?
What is the market cap of DIH Holdings US (DHAI)?
